RESUMEN
Alarin, a 25 amino acid splice variant of the galanin-like peptide, was originally discovered in gangliocytes of neuroblastic tumors and shown to be expressed in ganglioneuroblastoma and ganglioneuroma but not in undifferentiated neuroblastoma. Recently, in vivo studies have elucidated the physiological functions of alarin in the central nervous system (CNS). Alarin was shown to stimulate food intake, increase body weight, induce luteinizing hormone secretion and stimulate fos-expression in rats; the anatomical localization for these functions correlates well with the varied distribution of the alarin peptide in the brain. Because alarin was originally detected in neuroblastic tumors and is present in a wide range of nuclei in the CNS, we determined in the present study the expression of alarin in a variety of CNS tumors. Immunohistochemical analysis of 179 tumor samples resulted in different alarin-like immunoreactivity (alarin-LI) intensities, which were score-rated from 0 (no alarin stainin), 1 (low intensity), 2 (medium intensity) to 3 (high intensity). Immunohistochemical analyses revealed score 2 or 3 alarin-LI in all choroid plexus tumors (100 %, 7/7) and in the majority of ependymomas (90 %, 52/58), but only in a minority of astrocytomas (15 %, 5/33), meningiomas (14 %, 7/49) and tumors of the cranial nerves (7 %, 1/15). In oligodendrogliomas (0 %, 0/12) and oligoastrocytoma (0 %, 0/5) alarin-LI was not detectable. The high specificity (83 %) of alarin-LI suggests that it might be used as a diagnostic marker for ependymoma in differentiating them from other gliomas such as astrocytomas and oligodendrogliomas.
Asunto(s)
Neoplasias del Plexo Coroideo/metabolismo , Ependimoma/metabolismo , Péptido Similar a Galanina/metabolismo , Adulto , Astrocitoma/metabolismo , Astrocitoma/patología , Neoplasias del Plexo Coroideo/patología , Neoplasias de los Nervios Craneales/metabolismo , Neoplasias de los Nervios Craneales/patología , Ependimoma/diagnóstico , Ependimoma/patología , Femenino , Humanos , Inmunohistoquímica , Masculino , Meningioma/metabolismo , Meningioma/patología , Persona de Mediana Edad , Oligodendroglioma/metabolismo , Oligodendroglioma/patología , Sensibilidad y EspecificidadRESUMEN
AIMS: Recent evidence suggests that the purinoceptor P2X7 may be involved in the development of dysesthesia following nerve injury, therefore, the aim of the present study was to investigate whether a correlation exists between the level of P2X7 receptor expression in damaged human lingual nerves and the severity of the patients' symptoms. METHODS: Neuroma-in-continuity specimens were obtained from patients undergoing surgical repair of the damaged lingual nerve. Specimens were categorized preoperatively according to the presence or absence of dysesthesia, and visual analog scales scores were used to record the degree of pain, tingling, and discomfort. Indirect immunofluorescence using antibodies raised against S-100 (a Schwann cell marker) and P2X7 was employed to quantify the percentage area of S-100 positive cells that also expressed P2X7. RESULTS: P2X7 was found to be expressed in Schwann cells of lingual nerve neuromas. No significant difference was found between the level of P2X7 expression in patients with or without symptoms of dysesthesia, and no relationship was observed between P2X7 expression and VAS scores for pain, tingling, or discomfort. No correlation was found between P2X7 expression and the time between initial injury and nerve repair. CONCLUSION: These data show that P2X7 is expressed in human lingual nerve neuromas from patients with and without dysesthesia. It therefore appears that the level of P2X7 expression at the injury site may not be linked to the maintenance of neuropathic pain after lingual nerve injury.
Asunto(s)
Neoplasias de los Nervios Craneales/metabolismo , Dolor Facial/fisiopatología , Traumatismos del Nervio Lingual , Neuroma/metabolismo , Receptores Purinérgicos P2/biosíntesis , Adulto , Neoplasias de los Nervios Craneales/fisiopatología , Femenino , Técnica del Anticuerpo Fluorescente Indirecta , Humanos , Nervio Lingual/metabolismo , Masculino , Neuroma/fisiopatología , Parestesia/metabolismo , Receptores Purinérgicos P2/análisis , Receptores Purinérgicos P2X7 , Proteínas S100/análisis , Células de Schwann/metabolismo , Adulto JovenRESUMEN
The INI1/SMARCB1 protein product (INI1), a component of a transcription complex, was recently implicated in the pathogenesis of schwannomas in two members of a single family with familial schwannomatosis. Tumors were found to have both constitutional and somatic mutations of the SMARCB1 gene and showed a mosaic pattern of loss of INI1 expression by immunohistochemistry, suggesting a tumor composition of mixed null and haploinsufficient cells. To determine if this finding could be extended to all tumors arising in familial schwannomatosis, and how it compares with other multiple schwannoma syndromes [sporadic schwannomatosis and neurofibromatosis 2 (NF2)] as well as to sporadic, solitary schwannomas, we performed an immunohistochemistry analysis on 45 schwannomas from patients with multiple schwannoma syndromes and on 38 solitary, sporadic schwannomas from non-syndromic patients. A mosaic pattern of INI1 expression was seen in 93% of tumors from familial schwannomatosis patients, 55% of tumors from sporadic schwannomatosis, 83% of NF2-associated tumors and only 5% of solitary, sporadic schwannomas. These results confirm a role for INI1/SMARCB1 in multiple schwannoma syndromes and suggest that a different pathway of tumorigenesis occurs in solitary, sporadic tumors.
Asunto(s)
Proteínas Cromosómicas no Histona/genética , Proteínas Cromosómicas no Histona/metabolismo , Neoplasias de los Nervios Craneales/genética , Neoplasias de los Nervios Craneales/metabolismo , Proteínas de Unión al ADN/genética , Proteínas de Unión al ADN/metabolismo , Neoplasias Primarias Secundarias/genética , Neoplasias Primarias Secundarias/metabolismo , Neurilemoma/genética , Neurilemoma/metabolismo , Factores de Transcripción/genética , Factores de Transcripción/metabolismo , Proteínas Cromosómicas no Histona/análisis , Neoplasias de los Nervios Craneales/patología , Análisis Mutacional de ADN , Proteínas de Unión al ADN/análisis , Diagnóstico Diferencial , Regulación Neoplásica de la Expresión Génica/genética , Marcadores Genéticos/genética , Predisposición Genética a la Enfermedad/genética , Pruebas Genéticas , Genotipo , Humanos , Inmunohistoquímica , Neoplasias Primarias Secundarias/patología , Neurilemoma/patología , Neurofibromina 2/genética , Proteína SMARCB1 , Factores de Transcripción/análisisRESUMEN
Expression of the transforming growth factor-beta (TGF-beta) protein family in the peripheral nervous system is well established, but the role of their cognate receptors TGF-beta receptor type 1 (R1) and type 2 (R2) has been less well studied. TGF-beta plays an essential role in Schwann cell proliferation and differentiation, and is involved in neurotrophic effects of several neurotrophic substances. TGF-beta is also expressed in benign peripheral nervous system tumors such as vestibular schwannomas. In the present study, we aimed to detect TGF-beta R1 and R2 in a total of 40 sporadic vestibular schwannomas using immunohistochemistry, and correlated the findings to essential clinicopathologic data. TGF-beta, TGF-beta R1, and TGF-beta R2 mRNA was further analyzed by RT-PCR in six vestibular schwannomas. TGF-beta R1 immunoexpression was found in about 95% of the tumors. TGF-beta R1 was equally present in Antoni A and Antoni B areas of the tumors. TGF-beta R2 was found immunohistochemically in 77%. In addition, all tumors showed strong expression of TGF-beta. No correlation between TGF-beta R1 or R2 expression and clinicopathologic parameters such as age, sex, clinical symptoms, growth pattern, and proliferation acitivity as measured by Ki-67 (MIB-1) staining was found. Moreover, all schwannomas studied contained TGF-beta, TGF-beta R1, and TGF-beta R2 mRNA. Therefore, the TGF-beta/TGF-beta R1 and -R2 system is present in human schwannomas, but its biologic role for tumor development and growth remains unclear.
Asunto(s)
Neoplasias de los Nervios Craneales/metabolismo , Neurilemoma/metabolismo , Receptores de Factores de Crecimiento Transformadores beta/biosíntesis , Enfermedades del Nervio Vestibulococlear/metabolismo , Neoplasias de los Nervios Craneales/patología , Humanos , Inmunohistoquímica , Neurilemoma/patología , ARN Mensajero/análisis , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Enfermedades del Nervio Vestibulococlear/patologíaRESUMEN
OBJECTIVE: Peripheral branches of the trigeminal nerve are often damaged during the removal of lower third molar teeth, and a small proportion of patients who sustain an injury develop persistent chronic pain. The cause of the pain is not clear and there are no satisfactory methods of treatment. The aim of the present study was to examine the expression of the sodium channel subtype Na(v)1.7 in damaged human lingual nerves, and to identify any association between Na(v)1.7 expression and reported symptoms of dysaesthesia. METHODS: Eleven neuromas-in-continuity (NICs) and 11 nerve-end neuromas (NENs) were studied, and were all obtained at the time of surgical repair of the damaged lingual nerve. Specimens were categorised as being obtained from patients with symptoms or without symptoms, according to the degree of pain, tingling or discomfort that had been experienced. The tissue was prepared and processed for indirect immunofluorescence, and image analysis was used to quantify the percentage area of PGP 9.5-labelled tissue that also contained Na(v)1.7. RESULTS: The results demonstrated that sodium channel Na(v)1.7 was expressed in human lingual nerve neuromas. There was no direct relationship between the level of expression of Na(v)1.7 and the patients' symptoms of dysaesthesia. However, in NICs there was found to be an inverse correlation between Na(v)1.7 and macrophage expression, and in symptomatic NICs a direct correlation was found between Na(v)1.7 expression and axonal apposition. CONCLUSIONS: These data suggest that Na(v)1.7 expression alone does not play a primary role in initiating the painful symptoms of dysaesthesia. The development of neuropathic pain may involve complex interactions including changes in ultrastructure and ion channel density.
Asunto(s)
Neoplasias de los Nervios Craneales/metabolismo , Nervio Lingual/metabolismo , Neuroma/metabolismo , Canales de Sodio/análisis , Axones/patología , Biomarcadores de Tumor/análisis , Neoplasias de los Nervios Craneales/patología , Técnica del Anticuerpo Fluorescente Indirecta , Humanos , Procesamiento de Imagen Asistido por Computador , Nervio Lingual/patología , Macrófagos/patología , Canal de Sodio Activado por Voltaje NAV1.7 , Neuroma/patología , Parestesia/metabolismo , Parestesia/patología , Estudios Prospectivos , Método Simple Ciego , Lengua/inervación , Enfermedades de la Lengua/metabolismo , Enfermedades de la Lengua/patología , Ubiquitina Tiolesterasa/análisisRESUMEN
ErbB-1 and 2 are receptor tyrosine kinases expressed in malignant tumours. Heterodimers of the ErbB family confer aggressive malignant behaviour, but homodimers are regarded as being less active. Using immunohistochemistry and Western blot techniques we have shown an increased expression of ErbB-2 and no expression of ErbB-1 in vestibular schwannomas (VS). Immunoprecipitation of the ErbB-2 in VS showed less activity when compared to glioblastoma multiforme. These findings implicate a functional role of ErbB-2 in the benign nature of VS and that a rationale for using ErbB targeted therapies in VS may be warranted.
Asunto(s)
Neoplasias de los Nervios Craneales/metabolismo , Receptores ErbB/biosíntesis , Neuroma Acústico/metabolismo , Receptor ErbB-2/biosíntesis , Animales , Western Blotting , Neoplasias Encefálicas/metabolismo , Neoplasias Encefálicas/patología , Células Cultivadas , Neoplasias de los Nervios Craneales/patología , Glioblastoma/metabolismo , Glioblastoma/patología , Humanos , Inmunohistoquímica , Inmunoprecipitación , Ratones , Proteínas de Neoplasias/química , Proteínas de Neoplasias/aislamiento & purificación , Neuroma Acústico/patologíaRESUMEN
BACKGROUND: Although the diagnosis and treatment of eighth cranial nerve (VIII CN) schwannoma (acoustic neuroma) has improved over the years, no factors capable of predicting tumor growth have been identified as yet. This study is a preliminary investigation of the expression in sporadic VIII CN schwannomas of Yes-associated protein (YAP), transcriptional coactivator with PDZ-binding motif (TAZ), and amphiregulin (AREG), a direct target gene of YAP and TAZ. The expression of YAP, TAZ and AREG was correlated with the volumetric dimensions of tumors on contrast-enhanced magnetic resonance imaging (ceMRI). METHODS: YAP, TAZ and AREG expression was assessed immunohistochemically in surgical specimens of 36 consecutive sporadic VIII CN schwannomas. 3D reconstructions of the tumors and their corresponding volumes in cm3 were obtained from measurements on ceMRI images using the OsiriX® software. RESULTS: We found a significant direct correlation between TAZ expression and VIII CN schwannoma volumes on latest preoperative ceMRI (p<0.0003). Mean TAZ expression was also significantly higher in VIII CN schwannomas with a volume ≥2.1 cm3 than in those with a volume <2.1 cm3(p<0.0018). No significant correlations emerged for YAP or AREG expression and VIII CN schwannoma volume. CONCLUSIONS: The immunohistochemical expression of TAZ (but not YAP or AREG) correlated significantly with schwannoma volume measured on ceMRI. Further investigations are needed to identify the biological factors influencing tumor proliferation (ideally secreted proteins like AREG) that might be detected using non-invasive approaches (i.e., blood samples).
Asunto(s)
Proteínas Adaptadoras Transductoras de Señales/biosíntesis , Anfirregulina/biosíntesis , Neoplasias de los Nervios Craneales/metabolismo , Neurilemoma/metabolismo , Fosfoproteínas/biosíntesis , Factores de Transcripción/biosíntesis , Nervio Vestibulococlear/patología , Aciltransferasas , Proteínas Adaptadoras Transductoras de Señales/genética , Anfirregulina/genética , Neoplasias de los Nervios Craneales/diagnóstico por imagen , Neoplasias de los Nervios Craneales/genética , Femenino , Humanos , Inmunohistoquímica , Masculino , Persona de Mediana Edad , Neurilemoma/diagnóstico por imagen , Neurilemoma/genética , Neurilemoma/patología , Fosfoproteínas/genética , Factores de Transcripción/genética , Nervio Vestibulococlear/diagnóstico por imagen , Proteínas Señalizadoras YAPRESUMEN
The expression of epidermal growth factor receptor (EGFR) and leucine-rich repeats and immunoglobulin-like domain 1 (LRIG-1) in human trigeminal neurinoma was investigated and their effect on the origination and development of trigeminal neurinoma, and the relationship between them was studied. By using immunohistochemistry with tissue chip, the expression of EGFR and LRIG-1 was detected in 23 cases of trigeminal neurinoma. It was found that in the 23 cases, the expression rate of EGFR was 21.74%, while that of the LRIG-1 was 78.26%. There was a negative correlation between them. It was suggested that LRIG-1 might inhibit the malignant differentiation and proliferation of the trigeminal neurinoma possibly by the negative feedback loop of EGFR.
Asunto(s)
Neoplasias de los Nervios Craneales/metabolismo , Receptores ErbB/biosíntesis , Glicoproteínas de Membrana/biosíntesis , Neurilemoma/metabolismo , Enfermedades del Nervio Trigémino/metabolismo , Adulto , Anciano , Receptores ErbB/genética , Femenino , Humanos , Masculino , Glicoproteínas de Membrana/genética , Persona de Mediana EdadRESUMEN
Previous low-resolution schwannoma studies have reported diverse frequencies (30-80%) of 22q deletions, involving the neurofibromatosis-2 tumor suppressor (NF2) gene. We constructed an array spanning 11 million base pairs of 22q encompassing the NF2 gene, with 100% coverage and an average resolution of 58 kb. Moreover, the 220 kb genomic sequence encompassing the NF2 gene was covered by 13 cosmids to further enhance the resolution of analysis. The rationale of this array-CGH study was to map and size 22q deletions around the NF2 gene in sporadic schwannoma using a reliable method with maximal resolution. We studied tumor and constitutional DNA from 47 patients and detected heterozygous deletions in 21 (45%) tumors, which could be classified into three profiles. The predominant profile (12/21) was a continuous deletion of the 11 Mb segment, consistent with monosomy 22. The second profile, comprising five schwannomas, was also in agreement with a continuous 11 Mb heterozygous deletion. However, these displayed a distinctly different level of deletion when compared to the first profile, suggesting a considerable amount of normal tissue in the tumor samples. This is the first report demonstrating the sensitivity of array-CGH to discriminate such samples. The third profile was composed of four cases displaying interstitial deletions of various sizes. Two of these did not encompass the NF2 locus, which further emphasize the importance of other loci in schwannoma development. This is the first high-resolution study performed on a large series of tumors, using an array continuously covering 1/3 of a human chromosome. Our findings warrant further studies of an extended tumor series on a full 22q genomic array, to better define additional, putative 22q-located loci important for schwannoma development. Our array also provides a new diagnostic tool for analysis of NF2 gene deletions in patients affected with neurofibromatosis-2.
Asunto(s)
Cromosomas Humanos Par 22/genética , Perfilación de la Expresión Génica , Genes de la Neurofibromatosis 2 , Proteínas de Neoplasias/genética , Neurilemoma/genética , Hibridación de Ácido Nucleico , Análisis de Secuencia por Matrices de Oligonucleótidos , Adulto , Anciano , Neoplasias de los Nervios Craneales/genética , Neoplasias de los Nervios Craneales/metabolismo , Femenino , Humanos , Pérdida de Heterocigocidad , Masculino , Persona de Mediana Edad , Monosomía , Proteínas de Neoplasias/biosíntesis , Neurilemoma/metabolismo , Neuroma Acústico/genética , Neuroma Acústico/metabolismo , Neoplasias del Sistema Nervioso Periférico/genética , Neoplasias del Sistema Nervioso Periférico/metabolismo , Eliminación de Secuencia , Nervios EspinalesRESUMEN
A 71-year-old woman developed chronic progressive visual loss in the right eye and computed tomographic scan showed enlargement of the intraorbital optic nerve consistent with optic nerve sheath meningioma. Over 12 years, the contralateral optic nerve was not clinically affected, and serial neuroradiologic imaging showed no evidence of intracranial tumor extension. Death occurred from metastatic adenocarcinoma of the lung 14 years after initial visual loss. Examination of the postmortem specimen of optic nerve and chiasm revealed extradural extension of meningioma with spread to the region of the optic chiasm and hypothalamus. A large focus of metastatic adenocarcinoma was present within the intraorbital portion of the meningioma. Carcinoma metastatic to intracranial meningioma is rare; to our knowledge, this is the first reported case in an optic nerve sheath meningioma. Neuroimaging may be inadequate to predict the value of tumor excision in preventing intracranial spread of optic nerve sheath meningioma.
Asunto(s)
Adenocarcinoma/secundario , Neoplasias de los Nervios Craneales/metabolismo , Neoplasias Pulmonares/patología , Meningioma/patología , Neoplasias Primarias Secundarias , Enfermedades del Nervio Óptico/patología , Adenocarcinoma/patología , Anciano , Neoplasias de los Nervios Craneales/patología , Femenino , Humanos , Imagen por Resonancia Magnética , Vaina de Mielina/patología , Neoplasias Primarias Secundarias/patología , Quiasma Óptico/patología , Nervio Óptico/patologíaRESUMEN
OBJECTIVE: Magnetic resonance imaging and computed tomography provide good anatomic detail of suprasellar tumors in pediatric patients but are not able to predict histology in many cases. Proton magnetic resonance spectroscopy provides metabolic data that may add to diagnostic specificity. We preoperatively performed localized proton magnetic resonance spectroscopy on pediatric patients with suprasellar tumors and correlated the results with the histological findings. Cyst fluid obtained from patients with craniopharyngiomas was studied with high-resolution magnetic resonance spectroscopy to better understand the in vivo data. METHODS: Nineteen patients aged 1 to 21 years underwent spectroscopy. Surgical pathological samples were obtained from 14 patients. In each of five patients, the presence of a solid chiasmatic mass in addition to clinical evidence of neurofibromatosis Type I allowed the presumptive diagnosis of chiasmatic astrocytoma. Thus, the study population included 6 patients with craniopharyngiomas, 10 with chiasmatic/hypothalamic astrocytomas, and 3 with pituitary adenomas. The data obtained were compared with those of healthy brain from age-matched participants. RESULTS: Spectroscopy was specific for the diagnosis. All craniopharyngiomas showed a dominant peak at 1 to 2 ppm, consistent with lactate or lipids, with trace amounts of other metabolites. This was confirmed using high-resolution spectroscopy. Chiasmatic gliomas showed a profile of choline, N-acetylaspartate, and creatine, and the choline:N-acetylaspartate ratio was 2.6 +/- 1.3, compared with 0.7 +/- 0.3 for samples of healthy brain (t test, P = 0.0003). Pituitary adenomas showed only a choline peak or no metabolites at all. CONCLUSION: Proton spectroscopy may be helpful in supplementing standard imaging for the preoperative diagnosis of three types of suprasellar tumors that are common in pediatric patients.
Asunto(s)
Astrocitoma/diagnóstico , Neoplasias de los Nervios Craneales/diagnóstico , Neoplasias Hipotalámicas/diagnóstico , Espectroscopía de Resonancia Magnética , Neoplasias Hipofisarias/diagnóstico , Silla Turca , Adenoma/diagnóstico , Adenoma/metabolismo , Adolescente , Adulto , Astrocitoma/metabolismo , Niño , Preescolar , Neoplasias de los Nervios Craneales/metabolismo , Craneofaringioma/diagnóstico , Craneofaringioma/metabolismo , Humanos , Neoplasias Hipotalámicas/metabolismo , Lactante , Quiasma Óptico/patología , Neoplasias Hipofisarias/metabolismoRESUMEN
OBJECTIVE: Vestibular schwannomas (VSs) are known to be relatively slow-growing tumors. Some VSs, however, rapidly regrow or recur after surgical resection. Our objective was to investigate the clinicopathological characteristics of these tumors and to elucidate factors that can predict rapid regrowth or recurrence after surgical resection. METHODS: Between 1978 and 2000, 29 patients with VS underwent reoperation for regrowth or recurrence at the Department of Neurosurgery in Seoul National University Hospital. Among these patients, 15 experienced rapid VS regrowth or recurrence (annual growth rate, >15 mm/yr). The clinical, radiological, operative, and pathological findings were reviewed. For a comparison of the morphology and proliferative activity, 15 cases of VS were randomly selected as a control group from among the consecutive operative cases with tumor size larger than 4 cm treated between 1991 and 1999. Pathological parameters consisting of cellularity, pleomorphism, mitosis, necrosis, invasion to adjacent tissue, and microvascular proliferation were analyzed. Proliferative indices (e.g., Ki-67 index) also were evaluated. Statistical analyses were performed using Fisher's exact test and the analysis of variance test. RESULTS: The differences in clinical features between the aggressive VS group and the control VS group were nonspecific. The mean ages at diagnosis were 40.6 years (range, 21-63 yr) and 49.7 years (range, 35-67 yr) (P = 0.438), and the male-to-female ratios were 7:7 and 5:10 (P = 0.462), respectively. The clinical symptoms and signs were similar between the two groups. Radiologically, aggressive tumors at initial presentation had more lobulating contours than those in the control group (7 of 13 cases versus 3 of 15 cases; P = 0.001). In pathological findings, cellularity and pleomorphism were significantly higher than those in the control group (P = 0.001). However, mitosis, necrosis, invasion to adjacent tissue, and microvascular proliferation were not different between the two groups. The proliferative index (Ki-67 index) was higher in the aggressive group than in the control group (2.28 [range, 0.1-8.6] versus 0.59 [range, 0-1.5]; P = 0.034). CONCLUSION: VSs presenting with lobulating contour, high proliferative index (Ki-67 index), and high cellularity or pleomorphism require frequent radiological investigation during follow-up to facilitate early detection of regrowth or recurrence.
Asunto(s)
Neoplasias de los Nervios Craneales/patología , Neoplasias de los Nervios Craneales/cirugía , Neurilemoma/patología , Neurilemoma/cirugía , Enfermedades del Nervio Vestibulococlear/patología , Enfermedades del Nervio Vestibulococlear/cirugía , Adulto , Anciano , División Celular , Neoplasias de los Nervios Craneales/diagnóstico , Neoplasias de los Nervios Craneales/metabolismo , Femenino , Humanos , Antígeno Ki-67/metabolismo , Imagen por Resonancia Magnética , Masculino , Persona de Mediana Edad , Recurrencia Local de Neoplasia , Neurilemoma/diagnóstico , Neurilemoma/metabolismo , Factores de Tiempo , Enfermedades del Nervio Vestibulococlear/diagnóstico , Enfermedades del Nervio Vestibulococlear/metabolismoRESUMEN
A case is reported of malignant schwannomatosis (malignant transformation of von Recklinghausen's disease) with catecholamine production in a patient with multiple intracranial aneurysms. The patient had a history of episodic hypertension and elevated levels of catecholamines in the serum and 24-hour urinary excretion. Postmortem examination revealed diffuse central nervous system (CNS) dissemination of the tumor from the thoracolumbar spinal malignant schwannoma. A high concentration of catecholamines was demonstrated in the tumor tissue, and histochemical and electron microscopy studies suggested the presence of catecholamines in the cytoplasm of some of the tumor cells. This patient's clinical and radiological features, including severe headache, vomiting, stiff neck, ptosis of the eye ipsilateral to the internal carotid-posterior communicating artery aneurysms, and local arterial narrowing, mimicked those of subarachnoid hemorrhage from a ruptured aneurysm. However, the clinical picture was caused by diffuse CNS dissemination of the tumor, another primary malignant schwannoma of the oculomotor nerve, and intimal fibrous thickening of the arterial wall.
Asunto(s)
Neoplasias de los Nervios Craneales/complicaciones , Aneurisma Intracraneal/complicaciones , Neurilemoma/complicaciones , Neurofibromatosis 1/complicaciones , Neoplasias de los Nervios Craneales/diagnóstico , Neoplasias de los Nervios Craneales/metabolismo , Neoplasias de los Nervios Craneales/cirugía , Epinefrina/metabolismo , Humanos , Aneurisma Intracraneal/diagnóstico , Aneurisma Intracraneal/cirugía , Masculino , Persona de Mediana Edad , Neurilemoma/diagnóstico , Neurilemoma/metabolismo , Neurilemoma/cirugía , Neurofibromatosis 1/diagnóstico , Neurofibromatosis 1/metabolismo , Neurofibromatosis 1/cirugía , Norepinefrina/metabolismoRESUMEN
We report studies of schwannomas with a high percentage of MIB-1 positive cells. Thirty-eight specimens from 36 cases of schwannoma in the intracranial and spinal regions comprise the substance of this study. The MIB-1 positive cells were measured using immunohistochemical staining. In nine cases with a positivity index (PI) of 5% or more, immunohistochemical staining using DNA topoisomerase IIalpha (topo-II) and CD68 was performed. In some cases, we also searched for apoptosis with the TdT-mediated dUTP-biotin nick-end labeling (TUNEL) method. Three of nine cases with 5% or more positive MIB-1 cells had a very high cellularity with mitotic figures and were considered cellular Schwannomas. Their MIB-1 PI values were 8.21%, 10.00%, and 21.37%. However, the remaining six cases showed little evidence of malignancy. Their PIs were comparatively low, ranging from 5.19% to 8.41%, and the positive findings were localized in many cases. In these cases, we examined the sites where MIB-1 was measured and found that they corresponded to the borderline site between Antoni type A and B patterns and tended to be associated with an infiltration of CD68-positive macrophage. Furthermore, apoptotic cells appeared in the sites. With topo-II staining, the PIs in the same sites of these six cases were low, ranging from 0.78% to 1.93%. This implies that the high MIB-1 PI that was seen in these six cases was caused by reaction of MIB-1 to tumor cells that brought about an abnormality in the cell cycle by degeneration, such as apoptosis. In the site of formation of Antoni type B, MIB-1 may be a false positive in tumors with degenerative findings such as schwannomas. Topo-II was useful in these cases.
Asunto(s)
Neoplasias Encefálicas/patología , Nervio Coclear , Neoplasias de los Nervios Craneales/patología , Neurilemoma/patología , Neoplasias de la Columna Vertebral/patología , Adulto , Anciano , Antígenos Nucleares , Neoplasias Encefálicas/diagnóstico , Neoplasias Encefálicas/metabolismo , División Celular , Neoplasias de los Nervios Craneales/metabolismo , ADN-Topoisomerasas de Tipo II/metabolismo , Reacciones Falso Positivas , Femenino , Humanos , Inmunohistoquímica/métodos , Antígeno Ki-67 , Imagen por Resonancia Magnética , Masculino , Persona de Mediana Edad , Neurilemoma/diagnóstico , Neurilemoma/metabolismo , Proteínas Nucleares/metabolismo , Neoplasias de la Columna Vertebral/metabolismo , Coloración y EtiquetadoRESUMEN
Nerve growth factor (NGF) reduces the development of trigeminal neurinomas in vivo. To characterize the action of NGF on these tumors, clonal cells (476-16) isolated from a rat trigeminal neurinoma cell line were synchronized at early S phase by aphidicolin, a reversible inhibitor of DNA polymerase alpha, and effects of NGF on DNA replication were examined in vitro. While NGF did not inhibit DNA replication in the ongoing S phase, it reduced the level of DNA synthesis in the succeeding S phase without altering its timing and duration. The inhibitory action was elicited by a brief exposure to NGF during progression through the preceding S to G1 phases with decreasing effectiveness in the later stage of G1.
Asunto(s)
Neoplasias de los Nervios Craneales/tratamiento farmacológico , Neoplasias de los Nervios Craneales/patología , Factores de Crecimiento Nervioso/farmacología , Neurilemoma/tratamiento farmacológico , Neurilemoma/patología , Nervio Trigémino/patología , Animales , Afidicolina/farmacología , Ciclo Celular/efectos de los fármacos , Ciclo Celular/fisiología , División Celular/efectos de los fármacos , Células Clonales , Neoplasias de los Nervios Craneales/metabolismo , ADN de Neoplasias/biosíntesis , Etilnitrosourea , Masculino , Ratones , Neurilemoma/metabolismo , Ratas , Ratas Endogámicas F344 , Nervio Trigémino/metabolismo , Células Tumorales Cultivadas/efectos de los fármacosRESUMEN
The clinical presentation and histopathological features of 5 cases of malignant Schwannoma of cranial nerves are described. The ultrastructural appearances of one case and the pattern of nerve sheath cell differentiation of these tumours are also discussed. These uncommon tumours often are not diagnosed at initial presentation. Since the cases provide evidence that early diagnosis and surgical treatment are vital in the management of patients with this tumour criteria for its diagnosis are suggested.
Asunto(s)
Neoplasias de los Nervios Craneales/patología , Neurilemoma/patología , Adulto , Diferenciación Celular , Neoplasias de los Nervios Craneales/metabolismo , Neoplasias de los Nervios Craneales/ultraestructura , Diagnóstico Diferencial , Femenino , Humanos , Masculino , Melaninas/biosíntesis , Melanoma/metabolismo , Melanoma/patología , Persona de Mediana Edad , Vaina de Mielina/ultraestructura , Neurilemoma/metabolismo , Neurilemoma/ultraestructuraRESUMEN
An unprecedented presentation of multicentric paraganglioma in a 48-year-old man is described. One of the paragangliomas, originally diagnosed as a carcinoid tumor, presented as a lung mass and was removed. Four years later, an intravagal paraganglioma was discovered. The lung and intravagal tumors had identical morphologic and immunoreactive characteristics. Both tumors consisted of chief cells (type 1) and sustentacular cells (type 2). The chief cells were immunoreactive with neuroendocrine markers (synaptophysin and chromogranin), but nonreactive with epithelial markers (CAM 5.2, high- and low-molecular-weight keratins, epithelial membrane antigen, and carcinoembryonic antigen). The sustentacular cells were positive for S100 protein. Although pulmonary carcinoids may mimic paragangliomas and occasionally contain sustentacular cells, the diagnosis was rejected because the tumor cells did not demonstrate reactivity with epithelial markers.
Asunto(s)
Neoplasias de los Nervios Craneales/patología , Neoplasias Pulmonares/patología , Neoplasias Primarias Múltiples/patología , Paraganglioma/patología , Enfermedades del Nervio Vago/patología , Nervio Vago/patología , Biomarcadores de Tumor/metabolismo , Tumor Carcinoide/diagnóstico , Neoplasias de los Nervios Craneales/metabolismo , Neoplasias de los Nervios Craneales/cirugía , Diagnóstico Diferencial , Supervivencia sin Enfermedad , Humanos , Neoplasias Pulmonares/metabolismo , Masculino , Persona de Mediana Edad , Neoplasias Primarias Múltiples/metabolismo , Paraganglioma/metabolismo , Paraganglioma/cirugía , Vagotomía , Nervio Vago/metabolismo , Nervio Vago/cirugía , Enfermedades del Nervio Vago/metabolismo , Enfermedades del Nervio Vago/cirugíaRESUMEN
OBJECTIVES: Acoustic neurinoma (AN) can grow to a large size, but the growth-promoting molecular pathways remain unknown. As angiogenesis has been described as being activated in many cancers, we undertook this study in order to examine the microvascular network of AN and the expression of angiogenic growth factors and their cognate receptors in AN. The aim was to draw conclusions regarding the underlying mechanisms and potential benefit of a pathway-specific anticancer therapy. MATERIAL AND METHODS: Surgical specimens from 34 patients with AN were analysed immunohistochemically for the expression of vascular endothelial growth factor (VEGF), VEGF-receptor 1 (VEGF-R1), VEGF-receptor 2 (VEGF-R2) and transforming growth factor-beta1 (TGF-beta1). The microvessel density (MVD) was defined using CD31 staining and macrophage infiltration using CD68 staining. MVD was correlated to tumour size, patient age and duration of symptoms. RESULTS: With 1 exception each for VEGF and VEGF-R1, none of the 34 tumours expressed either VEGF, TGF-beta1, VEGF-R1 or -R2. No tumour-infiltrating macrophages were detected. The MVDs determined were low and did not correlate with tumour size, duration of symptoms or patient age. CONCLUSION: These findings indicate that ANs either do not express or express very low levels of the analysed proangiogenic growth factors. We conclude that tumour angiogenesis is not likely to be a relevant mechanism of AN growth and might therefore not be a suitable anticancer therapy target.
Asunto(s)
Inductores de la Angiogénesis/metabolismo , Neoplasias de los Nervios Craneales/metabolismo , Neuroma Acústico/metabolismo , Adulto , Anciano , Femenino , Humanos , Inmunohistoquímica , Masculino , Persona de Mediana Edad , Receptores de Factores de Crecimiento Endotelial Vascular/metabolismo , Factor de Crecimiento Transformador beta/metabolismo , Factor de Crecimiento Transformador beta1 , Factor A de Crecimiento Endotelial Vascular/metabolismoRESUMEN
OBJECTIVE: To analyze the clinical, radiological, and pathological features which may be useful to differentiate intracranial schwannomas of the facial nerve from vestibular schwannomas. MATERIAL AND METHODS: A retrospective study of 91 patients undergoing surgery with a clinical suspicion of vestibular schwannoma is presented. Clinical and radiological features are analyzed. Immunohistochemistry for neurofilaments was performed in selected cases of unilateral vestibular schwannomas, bilateral vestibular schwannomas, and facial nerve schwannomas. RESULTS: Facial function was normal in 83% of patients with vestibular schwannoma. Both patients with facial schwannomas had preoperative House-Brackmann grade II facial function. MRI showed no main differences between facial and vestibular schwannomas. A positive immunostaining was found in unilateral vestibular schwannomas, bilateral vestibular schwannomas, and facial nerve schwannomas. CONCLUSION: There are no specific clinical, radiological, or pathological factors to accurately differentiate schwannomas of the facial nerve from vestibular schwannomas.
Asunto(s)
Neoplasias de los Nervios Craneales/diagnóstico por imagen , Neoplasias de los Nervios Craneales/metabolismo , Nervio Facial/diagnóstico por imagen , Nervio Facial/metabolismo , Neurilemoma/diagnóstico por imagen , Neurilemoma/metabolismo , Proteínas de Neurofilamentos/metabolismo , Adolescente , Adulto , Anciano , Neoplasias de los Nervios Craneales/patología , Nervio Facial/patología , Femenino , Humanos , Inmunohistoquímica , Imagen por Resonancia Magnética , Masculino , Persona de Mediana Edad , Neurilemoma/patología , Radiografía , Estudios RetrospectivosRESUMEN
OBJECTIVE: Adenoid cystic carcinoma of the salivary glands has a propensity for perineural invasion, which could favor spread along the major cranial nerves, sometimes to the skull base and through the foramina to the brain parenchyma. This study evaluated the relationship between neural spread and relapse in the skull base. STUDY DESIGN: During surgery, we performed multiple biopsies with extemporaneous examination of the major nerves close to the tumor to guide the surgical resection. RESULTS: The percentage of actuarial local control at 5 years for patients with a positive named nerve and skull base infiltration was 12.5%, compared with 90.0% in patients who were named nerve-negative and without infiltration of the skull base (P = .001). CONCLUSIONS: Our study shows that local control of disease for patients who are named nerve-positive with skull base infiltration is significantly more complex compared with patients who are named nerve-negative without infiltration of the skull base.